Christoph Bock is a German bioinformatician and principal investigator at the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences and a visiting professor at the Medical University of Vienna.^[2][3]

Bock carried out his undergraduate studies at the University of Mannheim, focusing on computer science and business information, with an emphasis on machine learning.^[4]

Bock gained his PhD in 2008 from Saarland University for research carried out at the Max Planck Institute for Informatics on computational epigenetics supervised by Thomas Lengauer.^[4][1]

Following his PhD, he undertook postdoctoral research with Alexander Meissner at the Broad Institute, where he contributed to the NIH Roadmap Epigenomics Project.^[5]

Bock joined CeMM as a principal investigator in 2012.^{[citation needed]} His research focuses on the application of machine learning and biostatistics to computational epigenetics. He is also interested in the application of bioinformatics to epigenetic diagnosis and personalised medicine.^[5] Bock's lab has explored integrating technologies to efficiently assess the impact of many genes in gene regulation. His lab has combined CRISPR genome editing with single-cell RNA-seq to create the CROP-seq method, which enables high-throughput analysis of gene regulation.^[6]

Beyond his work at CeMM, he has also been a principal investigator of BLUEPRINT, a member organisation of the International Human Epigenome Consortium.^[5]